Pittenger & Anderson Inc’s CorMedix CRMD Stock Holding History

Pittenger & Anderson Inc’s Portfolio CRMD Stock Details CRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.79K	Hold	610	–	–	﹤0.01%	437
2026 Q1	$4.14K	Hold	610	–	–	﹤0.01%	440
2025 Q4	$7.09K	Hold	610	–	–	﹤0.01%	423
2025 Q3	$7.09K	Hold	610	–	–	﹤0.01%	379
2025 Q2	$7.52K	Hold	610	–	–	﹤0.01%	366
2025 Q1	$3.76K	Hold	610	–	–	﹤0.01%	389
2024 Q4	$4.94K	Hold	610	–	–	﹤0.01%	389
2024 Q3	$4.93K	Hold	610	–	–	﹤0.01%	407
2024 Q2	$2.64K	Hold	610	–	–	﹤0.01%	418
2024 Q1	$2.59K	Hold	610	–	–	﹤0.01%	400
2023 Q4	$2.29K	Hold	610	–	–	﹤0.01%	411
2023 Q3	$2.26K	Hold	610	–	–	﹤0.01%	397
2023 Q2	$2.42K	Hold	610	–	–	﹤0.01%	420
2023 Q1	$2.53K	Hold	610	–	–	﹤0.01%	406
2022 Q4	$2.57K	Hold	610	–	–	﹤0.01%	400
2022 Q3	$2K	Hold	610	–	–	﹤0.01%	416
2022 Q2	$2K	Hold	610	–	–	﹤0.01%	407
2022 Q1	$3K	Hold	610	–	–	﹤0.01%	404
2021 Q4	$3K	Hold	610	–	–	﹤0.01%	417
2021 Q3	$3K	Hold	610	–	–	﹤0.01%	410
2021 Q2	$4K	Hold	610	–	–	﹤0.01%	364
2021 Q1	$6K	Buy	610 +110	+22%	+$1.16K	﹤0.01%	333
2020 Q4	$4K	Hold	500	–	–	﹤0.01%	335
2020 Q3	$3K	Hold	500	–	–	﹤0.01%	332
2020 Q2	$3K	Hold	500	–	–	﹤0.01%	330
2020 Q1	$2K	Hold	500	–	–	﹤0.01%	327
2019 Q4	$4K	Hold	500	–	–	﹤0.01%	339
2019 Q3	$3K	Hold	500	–	–	﹤0.01%	343
2019 Q2	$4K	Hold	500	–	–	﹤0.01%	344
2019 Q1	$5K	Buy	+500	New	+$4.5K	﹤0.01%	346

Other funds holding CRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Pittenger & Anderson Inc's CRMD Position: Q2 2026 in Review

Pittenger & Anderson Inc held its CorMedix (CRMD) position steady in Q2 2026 at 610 shares worth $4.79K. The position accounts for ﹤0.01% of the portfolio, ranked #437.

Pittenger & Anderson Inc first reported a position in CRMD in Q1 2019 and has held it in 30 quarters since. The position peaked at $7.52K in Q2 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

Pittenger & Anderson Inc held 610 shares of CorMedix worth $4.79K as of Q2 2026.
Pittenger & Anderson Inc left its CorMedix share count unchanged in Q2 2026.
CorMedix made up ﹤0.01% of Pittenger & Anderson Inc's portfolio in Q2 2026, its #437 holding.
Pittenger & Anderson Inc first reported a position in CorMedix in Q1 2019 and has held it in 30 quarters since.
Pittenger & Anderson Inc's CorMedix position peaked at $7.52K in Q2 2025.
194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Pittenger & Anderson Inc's 13F filing for Q2 2026, filed 27 Jul 2026.